Literature DB >> 19192858

Effect of reinforcement probability and prize size on cocaine and heroin abstinence in prize-based contingency management.

Udi E Ghitza1, David H Epstein, John Schmittner, Massoud Vahabzadeh, Jia-Ling Lin, Kenzie L Preston.   

Abstract

Although treatment outcome in prize-based contingency management has been shown to depend on reinforcement schedule, the optimal schedule is still unknown. Therefore, we conducted a retrospective analysis of data from a randomized clinical trial (Ghitza et al., 2007) to determine the effects of the probability of winning a prize (low vs. high) and the size of the prize won (small, large, or jumbo) on likelihood of abstinence until the next urine-collection day for heroin and cocaine users (N=116) in methadone maintenance. Higher probability of winning, but not the size of individual prizes, was associated with a greater percentage of cocaine-negative, but not opiate-negative, urines.

Entities:  

Mesh:

Year:  2008        PMID: 19192858      PMCID: PMC2606595          DOI: 10.1901/jaba.2008.41-539

Source DB:  PubMed          Journal:  J Appl Behav Anal        ISSN: 0021-8855


  32 in total

1.  Behavioral momentum and the law of effect.

Authors:  J A Nevin; R C Grace
Journal:  Behav Brain Sci       Date:  2000-02       Impact factor: 12.579

2.  Contingency contracting with monetary reinforcers for abstinence from multiple drugs in a methadone program.

Authors:  N A Piotrowski; D J Tusel; K L Sees; P M Reilly; P Banys; P Meek; S M Hall
Journal:  Exp Clin Psychopharmacol       Date:  1999-11       Impact factor: 3.157

3.  A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar.

Authors:  J M Roll; S T Higgins
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

4.  Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.

Authors:  David H Epstein; Wesley E Hawkins; Lino Covi; Annie Umbricht; Kenzie L Preston
Journal:  Psychol Addict Behav       Date:  2003-03

5.  Single- versus dual-drug target: effects in a brief abstinence incentive procedure.

Authors:  Christopher J Correia; Jesse Dallery; Elizabeth C Katz; Kenneth Silverman; George Bigelow; Maxine L Stitzer
Journal:  Exp Clin Psychopharmacol       Date:  2003-11       Impact factor: 3.157

6.  Shaping cocaine abstinence by successive approximation.

Authors:  K L Preston; A Umbricht; C J Wong; D H Epstein
Journal:  J Consult Clin Psychol       Date:  2001-08

7.  Initial abstinence and success in achieving longer term cocaine abstinence.

Authors:  S T Higgins; G J Badger; A J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2000-08       Impact factor: 3.157

8.  The brief abstinence test: voucher-based reinforcement of cocaine abstinence.

Authors:  E Robles; K Silverman; K L Preston; E J Cone; E Katz; G E Bigelow; M L Stitzer
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

9.  Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients.

Authors:  Nancy M Petry; Bonnie Martin
Journal:  J Consult Clin Psychol       Date:  2002-04

10.  Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.

Authors:  J Dallery; K Silverman; M A Chutuape; G E Bigelow; M L Stitzer
Journal:  Exp Clin Psychopharmacol       Date:  2001-08       Impact factor: 3.157

View more
  9 in total

Review 1.  What's good for the goose is good for the gander. Guiding principles for the use of financial incentives in health behaviour change.

Authors:  Marita C Lynagh; Rob W Sanson-Fisher; Billie Bonevski
Journal:  Int J Behav Med       Date:  2013-03

2.  Using contingency management procedures to reduce at-risk drinking in heavy drinkers.

Authors:  Donald M Dougherty; Sarah L Lake; Nathalie Hill-Kapturczak; Yuanyuan Liang; Tara E Karns; Jillian Mullen; John D Roache
Journal:  Alcohol Clin Exp Res       Date:  2015-04       Impact factor: 3.455

3.  Amount of earnings during prize contingency management treatment is associated with posttreatment abstinence outcomes.

Authors:  Nancy M Petry; John M Roll
Journal:  Exp Clin Psychopharmacol       Date:  2011-06-27       Impact factor: 3.157

4.  Is exposure to an effective contingency management intervention associated with more positive provider beliefs?

Authors:  Kimberly C Kirby; Carolyn M Carpenedo; Maxine L Stitzer; Karen L Dugosh; Nancy M Petry; John M Roll; Michael E Saladin; Allan J Cohen; John Hamilton; Karen Reese; Gina R Sillo; Patricia Quinn Stabile; Robert C Sterling
Journal:  J Subst Abuse Treat       Date:  2011-11-23

5.  Automation in an addiction treatment research clinic: computerised contingency management, ecological momentary assessment and a protocol workflow system.

Authors:  Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein; Kenzie L Preston
Journal:  Drug Alcohol Rev       Date:  2009-01

Review 6.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29

7.  Introduction to the special issue on the behavior analysis and treatment of drug addiction.

Authors:  Kenneth Silverman; John M Roll; Stephen T Higgins
Journal:  J Appl Behav Anal       Date:  2008

Review 8.  The ABCs of incentive-based treatment in health care: a behavior analytic framework to inform research and practice.

Authors:  Steven E Meredith; Brantley P Jarvis; Bethany R Raiff; Alana M Rojewski; Allison Kurti; Rachel N Cassidy; Philip Erb; Jolene R Sy; Jesse Dallery
Journal:  Psychol Res Behav Manag       Date:  2014-03-19

9.  Electrophysiological predictors and indicators of contingency management treatment response: Rationale and design for the ways of rewarding abstinence project (WRAP).

Authors:  Sarah E Forster; Steven D Forman; Naomi N Gancz; Greg J Siegle; Michael Walsh Dickey; Stuart R Steinhauer
Journal:  Contemp Clin Trials Commun       Date:  2021-06-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.